"C-Reactive Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A plasma protein that circulates in increased amounts during inflammation and after tissue damage.
| Descriptor ID |
D002097
|
| MeSH Number(s) |
D12.776.034.145 D12.776.124.050.120 D12.776.124.486.157
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "C-Reactive Protein".
Below are MeSH descriptors whose meaning is more specific than "C-Reactive Protein".
This graph shows the total number of publications written about "C-Reactive Protein" by people in this website by year, and whether "C-Reactive Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 1 | 2 |
| 2001 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 4 | 2 | 6 |
| 2006 | 1 | 4 | 5 |
| 2007 | 0 | 4 | 4 |
| 2008 | 4 | 6 | 10 |
| 2009 | 3 | 4 | 7 |
| 2010 | 6 | 2 | 8 |
| 2011 | 4 | 6 | 10 |
| 2012 | 1 | 6 | 7 |
| 2013 | 3 | 4 | 7 |
| 2014 | 4 | 5 | 9 |
| 2015 | 0 | 9 | 9 |
| 2016 | 3 | 3 | 6 |
| 2017 | 1 | 3 | 4 |
| 2018 | 1 | 7 | 8 |
| 2019 | 0 | 4 | 4 |
| 2020 | 3 | 7 | 10 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "C-Reactive Protein" by people in Profiles.
-
A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab. Inflamm Bowel Dis. 2022 10 03; 28(10):1549-1554.
-
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. Gastroenterology. 2022 10; 163(4):950-964.
-
The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521. Int J Radiat Oncol Biol Phys. 2022 10 01; 114(2):266-274.
-
Regional and Sex-Specific Alterations in the Visual Cortex of Individuals With Psychosis Spectrum Disorders. Biol Psychiatry. 2022 09 01; 92(5):396-406.
-
Higher vs Standard Adalimumab Induction Dosing Regimens and?Two Maintenance Strategies: Randomized SERENE CD Trial?Results. Gastroenterology. 2022 06; 162(7):1876-1890.
-
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry. J Thorac Oncol. 2022 05; 17(5):661-674.
-
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study. J Crohns Colitis. 2021 Jul 05; 15(7):1120-1129.
-
Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity. Am J Physiol Endocrinol Metab. 2021 07 01; 321(1):E105-E121.
-
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
-
Serum Serotonin Differentiates Between Disease Activity States in Crohn's Patients. Inflamm Bowel Dis. 2020 09 18; 26(10):1607-1618.